Benzinga | Mar 4, 2021 07:24AM EST

WAVE Life Sciences Q4 EPS $(0.59) Beats $(0.61) Estimate, Sales $9.44M Miss $9.75M Estimate

WAVE Life Sciences (NASDAQ:WVE) reported quarterly losses of $(0.59) per share which beat the analyst consensus estimate of $(0.61) by 3.28 percent. This is a 64.24 percent increase over losses of $(1.65) per share from the same period last year. The company reported quarterly sales of $9.44 million which missed the analyst consensus estimate of $9.75 million by 3.19 percent. This is a 293.29 percent increase over sales of $2.40 million the same period last year.